Literature DB >> 9654262

Rates of first measles-mumps-rubella immunisation in Wales (UK)

D R Thomas, R L Salmon, J King.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654262     DOI: 10.1016/s0140-6736(98)24026-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals.

Authors:  P Duclos; C A Hofmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.

Authors:  M Pareek; H M Pattison
Journal:  Br J Gen Pract       Date:  2000-12       Impact factor: 5.386

3.  Parents' perspectives on the MMR immunisation: a focus group study.

Authors:  M Evans; H Stoddart; L Condon; E Freeman; M Grizzell; R Mullen
Journal:  Br J Gen Pract       Date:  2001-11       Impact factor: 5.386

4.  Are there altered antibody responses to measles, mumps, or rubella viruses in autism?

Authors:  Jane E Libbey; Hilary H Coon; Nikki J Kirkman; Thayne L Sweeten; Judith N Miller; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

5.  The impact of the media on the decision of parents in South Wales to accept measles-mumps-rubella (MMR) immunization.

Authors:  S Walsh; D Rh Thomas; B W Mason; M R Evans
Journal:  Epidemiol Infect       Date:  2015-02       Impact factor: 4.434

Review 6.  Measles vaccination and inflammatory bowel disease: controversy laid to rest?

Authors:  R L Davis; K Bohlke
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

7.  A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology.

Authors:  L Smeeth; A J Hall; E Fombonne; L C Rodrigues; X Huang; P G Smith
Journal:  BMC Public Health       Date:  2001-02-15       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.